Abbott Laboratories (NYSE:ABT) is included among the 15 Best Dividend Growth Stocks to Buy Now. On October 24, Citi analyst ...
Abbott Laboratories reported a 4% increase in quarterly sales, totalling $10.4 billion. The company released its latest earnings report Thursday and subsequently revised its full-year financial ...
Abbott Laboratories must pay $495 million in damages in the case of a girl who developed a serious gastrointestinal disease as a premature infant after consuming Abbott formula, a Missouri jury ...
A St. Louis judge has granted a new trial in a case Abbott Laboratories won in the fall, in which a mother alleged that the company’s cow’s milk-based products for premature infants contributed to her ...
The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm ...
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter ...
CHICAGO, July 12 (Reuters) - Abbott Laboratories Inc. may seek another buyer for its diagnostics business after its $8 billion deal to sell it to GE Healthcare fell through, Wall Street analysts said ...
If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing in Abbott Laboratories (NYSE: ABT). Abbott is a longtime leader in the ...
Shares of Abbott Laboratories (NYSE:ABT) are trading lower on Thursday following the company’s second-quarter 2024 financial results. What’s Going On: Abbott reported second-quarter sales of $10.377 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback